ArticleRecent patents on anti-cancer drug discovery2025

Tyrosine Kinase Inhibitor Lenvatinib Causes Cardiotoxicity by Inducing Endoplasmic Reticulum Stress and Apoptosis through Activating ATF6, IRE1α and PERK Signaling Pathways.

Siqi Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.